Hyatt Regency Boston1 Avenue de LafayetteBoston, MA 02111United States,

Boston,

MA,

US,

ZIP: 02111

Phone:

Diabetes Summit

 

GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 10-11, 2021 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes in three tracks.. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.

 

Joint Plenary Sessions:

1. Opening Keynote Session – Historical Perspective & Current State of the Industry

2. Round Table Discussions

3. Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch

4. Award Ceremony & Closing Keynote Session – Predictions for future

 

Track 1: Diabetes Drug Discovery & Development Conference

1. What’s New in Type I Diabetes – Targets, Models, Assays, etc.

2. Translational and Clinical Development for Type I Diabetes

3. What’s New in Type II Diabetes – Targets, Models, Assays, etc.

4. Translational and Clinical Development for Type II Diabetes

 

Track 2: Diabetes Partnering & Deal-Making Conference

1. Industry Partnering with Academia and CROs to Advance Research

2. Investments from Private, Institutional and Public Sources

 

Track 3: Devices and Digital Aids in Diabetes Management Conference

1. Next Generation Glucose Monitoring Devices and Technology

2. The Role of “Being Digitally Connected” in Diabetes Management

 

 

AGENDA

Day 1 – Monday, April 9, 2021

4:00 pm Registration Open
5:00 pm Opening Remarks by Dr. Satish Medicetty
5:10 pm Program Preview by Alan Cherrington
5:30 pm Focus Group Discussions – Part I (Challenges and Opportunities)
7:00 pm End of Day 1

 

Day 2 – Tuesday, April 10, 2021

Drug Discovery & Development for Diabetes
7:15 am Continental Breakfast & Registration
7:15 am Breakfast with Mentors from Academia & Industry (RSVP Only)
8:30 am 
Opening Keynote Session: Historical Perspective and State of the Industry

9:50 am Morning Networking Break

10:30 am Type I Diabetes – Preclinical and Clinical Development Drug
12:35 pm Lunch and Short-talks from poster presenters
2:00 pm Type II Diabetes – Preclinical and Clinical Development
4:05 pm Afternoon Networking Break
4:30 pm 
Devices and Digital Aids in Diabetes Management

5:30 pm Networking Reception & Poster Session

 

Day 3 – Wednesday, April 11, 2021

Funding, Partnering and Commercialization of Diabetes Technologies

7:00 am Continental Breakfast for All Attendees
7:15 am Focus Group Discussions – Part I (Challenges and Opportunities)
8:30 am I. Industry Partnering with Academia & CROs to Advance Diabetes Research
10:10 am Morning Networking Break
10:40 am II. Funding & Commercialization of Diabetes Technologies
12:20 pm Lunch Provided by GTCbio | New Company/Technology Showcase (5 companies with 10 minutes each)
1:30 pm Award Ceremony & Closing Keynote Session – Predictions for the Future
2:10 pm Keynote Panel Discussion
3:00 pm 
Conference Concludes

 

 

SPEAKER

Domenico Accili 
Professor of Medicine
Columbia University

 

Nir Barzilai 
Professor, Department of Medicine (Endocrinology); Professor, Department of Genetics
Albert Einstein College of Medicine

 

Brian Bloomquist 
Senior Director, Global External Research and Development
Eli Lilly

 

Andrew Young 
Vice President, Chief Scientific Officer
Intarcia

 

DISTINGUISHED SPEAKERS

Julia Babensee 
Associate Professor
Georgia Tech

William Bachovchin 
Professor, Department of Biochemistry
Tufts University School of Medicine

Jonathan Behr 
Managing Director
JDRF

Michael Brehm 
Associate Professor
University of Massachusetts Medical School

Alan Cherrington 
Professor of Molecular Physiology and Biophysics
Vanderbilt University

Joseph Cook 
President and Executive Chairman of the Board
Nusirt Inc.

Denise Faustman 
Director of Immunobiology; Associate Professor of Medicine
Massachusetts General Hospital; Harvard Medical School

Alexander (Zan) Fleming 
Executive Chairman
Kinexum

Robert Geho 
Co-Founder and Chief Executive Officer 
Diasome Pharmaceuticals Inc

Judith Gorski 
Global Director, Scientific Engagement
Crown Bioscience Inc.

Julia Greenstein 
Vice President, Research Strategy 
JDRF

Wende Hutton 
General Partner
Canaan

Scott Johnson 
Communications Lead
mySugr GmbH

Vijay Koya 
Senior Scientist
Boston Scientific

Martin Lafontaine 
Commercialization Consultant
Kinexum

David Maggs 
Chief Medical Officer
Fractyl Laboratories

Felicia Pagliuca 
Vice President, Cell Biology R&D
Semma Therapeutics

Steven Russell 
Assistant Professor of Medicine 
Harvard Medical School

Aaron Schwartz 
Director, R&D Innovation Sourcing 
Novo Nordisk Inc.

Donald Scott 
Professor in the Division of Endocrinology, Diabetes and Bone Disease
Icahn School of Medicine at Mount Sinai

Thomas Seoh 
Chief Executive Officer
Kinexum

Maria Trujillo 
Principal Scientist, Quantitative Pharmacology and Pharmacometrics
Merck & Co.

Michael Zemel 
Founder and Chief Scientific Officer
Nusirt Inc.

 

 

 

"Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorship

NO REFUNDS ALLOWED ON REGISTRATIONS
Prices may go up any time. Service fees included in pricing.
-----------------------------------------------------------------
This event is brought to you by:
Global Technology Community LLC - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL171011CEV CHA171109UPT MAR20211124REV

VIO180227UPD MYL180302UPD JOA180315CEV